JP2009538910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538910A5 JP2009538910A5 JP2009513222A JP2009513222A JP2009538910A5 JP 2009538910 A5 JP2009538910 A5 JP 2009538910A5 JP 2009513222 A JP2009513222 A JP 2009513222A JP 2009513222 A JP2009513222 A JP 2009513222A JP 2009538910 A5 JP2009538910 A5 JP 2009538910A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- naphthylsulfonyl
- indazol
- optionally substituted
- alaninamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81001406P | 2006-06-01 | 2006-06-01 | |
| PCT/US2007/012570 WO2007142905A2 (en) | 2006-06-01 | 2007-05-25 | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538910A JP2009538910A (ja) | 2009-11-12 |
| JP2009538910A5 true JP2009538910A5 (enExample) | 2011-07-28 |
Family
ID=38656560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513222A Withdrawn JP2009538910A (ja) | 2006-06-01 | 2007-05-25 | ５−ヒドロキシトリプタミン−６リガンドとしての１−スルホニルインダゾリルアミン誘導体および１−スルホニルインダゾリルアミド誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20070281922A1 (enExample) |
| EP (1) | EP2029550A2 (enExample) |
| JP (1) | JP2009538910A (enExample) |
| CN (1) | CN101432269A (enExample) |
| AU (1) | AU2007255042A1 (enExample) |
| BR (1) | BRPI0712730A2 (enExample) |
| CA (1) | CA2650082A1 (enExample) |
| MX (1) | MX2008015329A (enExample) |
| WO (1) | WO2007142905A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6063870B2 (ja) * | 2010-11-08 | 2017-01-18 | ライセラ・コーポレイション | ＲＯＲγ活性の阻害用のＮ−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療 |
| WO2013169864A2 (en) | 2012-05-08 | 2013-11-14 | Lycera Corporation | TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE |
| RU2014149136A (ru) | 2012-05-08 | 2016-07-10 | Мерк Шарп И Доум Корп. | ТЕТРАГИДРОНАФТИРИДИНОВЫЕ И РОДСТВЕННЫЕ БИЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ ДЛЯ ИНГИБИРОВАНИЯ RORγ АКТИВНОСТИ И ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ |
| US9809561B2 (en) | 2013-12-20 | 2017-11-07 | Merck Sharp & Dohme Corp. | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease |
| US9663502B2 (en) | 2013-12-20 | 2017-05-30 | Lycera Corporation | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease |
| US9783511B2 (en) | 2013-12-20 | 2017-10-10 | Lycera Corporation | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease |
| MX2016010998A (es) | 2014-02-27 | 2017-03-31 | Lycera Corp | Terapia celular adoptiva que usa un agonista de receptor huérfano gamma relacionado con receptor de ácido retinoico y métodos terapéuticos relacionados. |
| JP6523337B2 (ja) | 2014-05-05 | 2019-05-29 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用及び疾患治療のためのベンゼンスルホンアミド及び関連化合物 |
| US9896441B2 (en) | 2014-05-05 | 2018-02-20 | Lycera Corporation | Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease |
| US9550754B2 (en) * | 2014-09-11 | 2017-01-24 | AbbVie Deutschland GmbH & Co. KG | 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy |
| CA2975997A1 (en) | 2015-02-11 | 2016-08-18 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as rorgammat inhibitors and uses thereof |
| CA2982847A1 (en) | 2015-05-05 | 2016-11-10 | Lycera Corporation | Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease |
| HK1253734A1 (zh) | 2015-06-11 | 2019-06-28 | The Regents Of The University Of Michigan | 用作RORγ激动剂和用於治疗疾病的芳基二氢-2H-苯并[B][1，4]恶嗪磺酰胺和相关化合物 |
| CA3002850A1 (en) | 2015-10-27 | 2017-05-04 | Merck Sharp & Dohme Corp. | Substituted indazole compounds as rorgammat inhibitors and uses thereof |
| JP2018531958A (ja) | 2015-10-27 | 2018-11-01 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | ＲＯＲγＴ阻害薬としてのヘテロアリール置換安息香酸及びその使用 |
| AU2016344111A1 (en) | 2015-10-27 | 2018-05-10 | Merck Sharp & Dohme Corp. | Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
| TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| CN1293072C (zh) * | 2001-04-20 | 2007-01-03 | 惠氏公司 | 作为5－羟色胺－6配体的杂环基氧基－、－硫代－和－氨基吲哚衍生物 |
| AU2002309585B2 (en) * | 2001-04-20 | 2008-01-31 | Wyeth | Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
-
2007
- 2007-05-25 JP JP2009513222A patent/JP2009538910A/ja not_active Withdrawn
- 2007-05-25 MX MX2008015329A patent/MX2008015329A/es not_active Application Discontinuation
- 2007-05-25 WO PCT/US2007/012570 patent/WO2007142905A2/en not_active Ceased
- 2007-05-25 AU AU2007255042A patent/AU2007255042A1/en not_active Abandoned
- 2007-05-25 CN CNA200780015679XA patent/CN101432269A/zh active Pending
- 2007-05-25 EP EP07795389A patent/EP2029550A2/en not_active Withdrawn
- 2007-05-25 CA CA002650082A patent/CA2650082A1/en not_active Abandoned
- 2007-05-25 BR BRPI0712730-8A patent/BRPI0712730A2/pt not_active IP Right Cessation
- 2007-05-31 US US11/809,425 patent/US20070281922A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009538910A5 (enExample) | ||
| AU2018358157B2 (en) | Modulators of the integrated stress pathway | |
| AU2026200636A1 (en) | Substituted cycloalkyls as modulators of the integrated stress pathway | |
| JP6419072B2 (ja) | （ｓ）−３−（４−（（４−（モルホリノメチル）ベンジル）オキシ）−１−オキソイソインドリン−２−イル）ピペリジン−２，６−ジオンの塩及び固体形態、並びにそれらを含有する組成物及び使用方法 | |
| CA2743902C (en) | Substituted dioxopiperidinyl phthalimide derivatives | |
| JP6505023B2 (ja) | Ｃｎｓおよび他の障害を治療するための、ｐｄｅ４アイソザイムの阻害薬としてのアザベンゾイミダゾール化合物 | |
| JP2018515495A5 (enExample) | ||
| JP2019525962A (ja) | ケモカイン受容体調節剤及びそれの使用 | |
| JP6506833B2 (ja) | イミダゾピリダジン化合物 | |
| JP2011509309A5 (enExample) | ||
| JP2010538001A5 (enExample) | ||
| KR20160038008A (ko) | 브로모도메인 억제제로서 신규 퀴나졸리논 | |
| SI3018132T1 (en) | Condensed imidazole derivatives useful as IDO inhibitors | |
| JP6643247B2 (ja) | ガンマセクレターゼモジュレーターとしてのクロメンおよび１，１ａ，２，７Ｂ−テトラヒドロシクロプロパ［Ｃ］クロメンピリドピラジンジオン | |
| JP2008513498A5 (enExample) | ||
| JP2011517443A5 (enExample) | ||
| JP2020502092A5 (enExample) | ||
| TWI902445B (zh) | αvβ6整合素之抑制劑 | |
| JP2011506566A5 (enExample) | ||
| JP2013542267A5 (enExample) | ||
| JP2011530521A5 (enExample) | ||
| WO2019183145A1 (en) | Compounds and methods for ido and tdo modulation, and indications therefor | |
| TW201831460A (zh) | 雜芳基苯氧基苯甲醯胺kappa類鴉片配體 | |
| JP2007500168A5 (enExample) | ||
| JP2006519868A5 (enExample) |